Pietro Genovese

Faculty at Dana Farber / Boston Children’s @DFBC_PedCare. Advanced genetic engineering of hematopoiesis Lab.

[Pietro Genovese @Genovese_Lab]

Thrilled to see the great work from @danielevanbauer lab featured in @NatureBiotech! The discovery that a limited nucleotide pool in HSPCs constrains prime editing is a leap forward in gene editing technology. A huge shoutout to @SbastienLevesq4 and the entire team!

[Sébastien Levesque @SbastienLevesq4]

My postdoc work in the @danielevanbauer lab is out @NatureBiotech! We found that the limited nucleotide pool in hematopoietic stem and progenitor cells (HSPCs) constrains reverse transcription and thus prime editing (PE). https://t.co/SultcbhT21

[Sébastien Levesque @SbastienLevesq4]

My postdoc work in the @danielevanbauer lab is out @NatureBiotech! We found that the limited nucleotide pool in hematopoietic stem and progenitor cells (HSPCs) constrains reverse transcription and thus prime editing (PE). https://t.co/SultcbhT21

[Pietro Genovese @Genovese_Lab]

Very proud of your achievements @ferrari_sam93 !! It has been a privilege contributing in mentoring such amazing young scientist!

[Samuele Ferrari @ferrari_sam93]

I am deeply honored to receive the 2023 Early Career Investigator Award by @ESGCT at the Annual Congress in Brussels together with @alessionahmad. This prestigious recognition would not have been possible without my SR-Tiget colleagues and mentors @NaldiniLab and @Genovese_Lab.

[Pietro Genovese @Genovese_Lab]

@adam_thiesen @andrea_csn @elonmusk Thanks @adam_thiesen for the great overview of our work!

[Pietro Genovese @Genovese_Lab]

@GENbio Thanks to @GENbio for covering our work in this excellent article!

[Pietro Genovese @Genovese_Lab]

@davidrliu @Nature Thank David. Glad you enjoyed our work, and thanks very much for having developed such powerful precision gene editing tools.

[Pietro Genovese @Genovese_Lab]

Excited to share our latest publication about epitope editing in hematopoietic stem cells to enable targeted immunotherapy for acute myeloid leukemia. Congrats to @CasiratiG and all collaborators for this amazing work.

https://t.co/bTx6YoFDHJ

[Gabriele Casirati @CasiratiG]

I'm thrilled to announce that our work, 'Epitope Editing Enables Targeted Immunotherapy of Acute Myeloid Leukemia,' is out today in Nature journal!

Link: https://t.co/nC05EjWMPw
doi: https://t.co/t8CWop6Z4k

[Pietro Genovese @Genovese_Lab]

@ED_PhD_ Mongiove!! Great!

[Edilytics @edilytics]

Congrats to Zeng @Genovese_Lab @danielevanbauer et al. on their paper "Base Editing of Human Hematopoietic Stem Cells."

Thanks for using #crispresso2! https://t.co/Wo18eIm0dd

[BioCentury @BioCentury]

Gene editing stem cell transplants makes myeloid and T cell therapies safer, according to data at #ASH22 https://t.co/NssFPB5vYT

[ASGCT @ASGCTherapy]

With #geneediting, researchers restored levels of CTLA-4 in T cells from patients with CTLA-4 insufficiency. In mice, they improved symptoms.

ASGCT members involved: @RealDrfox, MbChB, PhD; Claire Booth, MBBS, PhD; Pietro Genovese @Genovese_Lab, PhD: https://t.co/BQUs3JX4mw.

[Pietro Genovese @Genovese_Lab]

@AlejoFraticelli Thanks Alejo, happy that you liked the work!

[Fyodor Urnov @UrnovFyodor]

"Unless things change dramatically, the millions of people #CRISPR could save will never benefit from it. We must, and we can, build a world with #CRISPR for all."
#healthjustice @igisci @nytimes
https://t.co/7VjfFdkLzJ

[Pietro Genovese @Genovese_Lab]

https://t.co/3BZFCvjQge ready to share our exciting data tomorrow morning!🩸#ASH22

[Pietro Genovese @Genovese_Lab]

@PauFerrol @jcornlab @EJPRareDiseases Congrats Paula and all the team! Great work!

[Pietro Genovese @Genovese_Lab]

@BKleinstiver @NIH_CommonFund @NIHDirector @CGM_MGH @MGHPathology @MassGeneralNews @connorjtou @RachelSilvers11 @Christiano_RRA @FerreiraSilvaJ @ap_kanneganti @EmilyM_King @Linyuan79834832 @AnnSophieKroell Congrats Ben! Very well deserved!

[Hematopoiesis News @Hema_News]

Researchers at @SanRaffaeleMI, led by Dr. Maria Ester Bernardo, developed an MSC-based co-culture system to optimize the transplantation outcome of #CRISPR-Cas9 gene-edited human #hematopoietic stem and progenitor cells. 🧬

#OpenAccess | 🔗 https://t.co/SpOmcmo4Cg

[Samuele Ferrari @ferrari_sam93]

Finally out in @MolTherapy our new work showing that #mesenchymal stromal cells help "hand-in-hand" #CRISPR/Cas9 edited human #hematopoietic #stem cells to engraft. By Bernardo's lab in coll with @DiMiccoLab and @NaldiniLab. https://t.co/80Hwdy3GUG. Pic created with DALL·E 2.

[Valentina Vavassori @ValentinaVavas2]

These are exciting but hard times for #genetherapy . It’s heartbreaking to witness withdrawal of effective gene therapies from the market. They are often the only cure for many rare conditions, saving lives of other human beings.
Don’t miss this!

[Alberto Angela @albertoangela]

Buon viaggio papà.